Clinical Trial Update: High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update for High Dose Dual Therapy aimed at eradicating Helicobacter pylori infection; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Helicobacter Pylori Infection

Snippet

Sponsor: Rabin Medical Center | Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori) | Phase 4 | Status: UNKNOWN